BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15180753)

  • 41. Cardiac involvement in hypereosinophilic syndrome.
    ten Oever J; Theunissen LJ; Tick LW; Verbunt RJ
    Neth J Med; 2011 May; 69(5):240-4. PubMed ID: 21793262
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The idiopathic hypereosinophilic syndrome and chronic eosinophilic leukemia].
    Chrobák L; Voglová J
    Vnitr Lek; 2005 Dec; 51(12):1385-93. PubMed ID: 16430106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oral mucosa lesions in hypereosinophilic syndrome--an update.
    Ionescu MA; Murata H; Janin A
    Oral Dis; 2008 Mar; 14(2):115-22. PubMed ID: 18194138
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eosinophilic disorders: molecular pathogenesis, new classification, and modern therapy.
    Gotlib J; Cross NC; Gilliland DG
    Best Pract Res Clin Haematol; 2006; 19(3):535-69. PubMed ID: 16781488
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Diagnostic Work-Up of Hypereosinophilia.
    Wang SA
    Pathobiology; 2019; 86(1):39-52. PubMed ID: 29961056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The Hypereosinophilic Syndromes in Childhood].
    Leu T; Simon HU; Hebestreit H; Kunzmann S
    Klin Padiatr; 2015 Nov; 227(6-7):308-13. PubMed ID: 26267413
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Imatinib mesylate treatment in two patients with idiopathic hypereosinophilic syndrome.
    Payne SM; Kovacs MJ
    Ann Pharmacother; 2004; 38(7-8):1215-8. PubMed ID: 15187212
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome.
    de Lavareille A; Roufosse F; Schmid-Grendelmeier P; Roumier AS; Schandené L; Cogan E; Simon HU; Goldman M
    J Allergy Clin Immunol; 2002 Sep; 110(3):476-9. PubMed ID: 12209097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anti-IL-5 and hypereosinophilic syndromes.
    Sutton SA; Assa'ad AH; Rothenberg ME
    Clin Immunol; 2005 Apr; 115(1):51-60. PubMed ID: 15870021
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Idiopathic hypereosinophilic syndrome].
    Sviri G; Rahamimov R; Ilan Y
    Harefuah; 1993 Oct; 125(7-8):201-5, 256. PubMed ID: 8225104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Spontaneous resolution of hypereosinophilic syndrome in an infant without treatment.
    Herrero B; de la Fuente JR; Aleo E; Carceller F; Lassaletta Á; Orellana MR; Pérez-Martínez A
    J Pediatr Hematol Oncol; 2012 Aug; 34(6):450-2. PubMed ID: 22510769
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Idiopathic hypereosinophilic syndrome: a report of four cases in Arabs, and a review of the literature.
    George BO; Abdelaal MA; Gangi MT; Kinsara AJ
    Afr J Med Med Sci; 2001 Sep; 30(3):241-9. PubMed ID: 14510138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Approach to the therapy of hypereosinophilic syndromes.
    Klion AD
    Immunol Allergy Clin North Am; 2007 Aug; 27(3):551-60. PubMed ID: 17868864
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The hypereosinophilic syndrome: case report].
    Mikołajczyk K; Zaba R; Walkowiak B; Grzybowski G; Samborski W
    Ann Acad Med Stetin; 2006; 52 Suppl 2():65-9. PubMed ID: 17471838
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Eosinophilia and Hypereosinophilic Disorders - Update on Etiopathogeny, Classification and Clinical Approach.
    Leru PM
    Rom J Intern Med; 2015; 53(4):289-95. PubMed ID: 26939204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular Pathogenesis and Treatment Perspectives for Hypereosinophilia and Hypereosinophilic Syndromes.
    Stella S; Massimino M; Manzella L; Pennisi MS; Tirrò E; Romano C; Vitale SR; Puma A; Tomarchio C; Gregorio SD; Palumbo GA; Vigneri P
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33418988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypereosinophilic syndromes.
    Kahn JE; Blétry O; Guillevin L
    Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):863-82. PubMed ID: 19028368
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Idiopathic eosinophilia with ascites (case report)].
    Anić B; Crkvencić N; Mayer M
    Lijec Vjesn; 2001; 123(11-12):308-12. PubMed ID: 11930757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?
    Iurlo A; Cattaneo D
    Blood Rev; 2023 Mar; 58():101014. PubMed ID: 36153195
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eosinophilic cholangiopathy with concurrent eosinophilic colitis in a patient with idiopathic hypereosinophilic syndrome.
    Sussman DA; Bejarano PA; Regev A
    Eur J Gastroenterol Hepatol; 2008 Jun; 20(6):574-7. PubMed ID: 18467919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.